Trevi Therapeutics
Nasdaq TRVI · New Haven, CT
Works in Dermatology · Psychiatry · Respiratory
Trevi Therapeutics is a clinical trial sponsor based in New Haven, CT, listed as Nasdaq TRVI. It has 3 active clinical trials with 607 planned participants, in Dermatology, Psychiatry and Respiratory. Since 2021 it has completed 14 trials and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq TRVI
Fundraising
Pipeline · 3 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Trevi Therapeutics
Trevi Therapeutics is lead sponsor of 3 active clinical trials on ClinicalTrials.gov, with 607 planned participants, in Dermatology, Psychiatry, Respiratory. Since 2021 it has completed 14 trials and stopped 0 early.
Trevi Therapeutics is based in New Haven, CT and is listed as Nasdaq TRVI. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Trevi Therapeutics; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-13.
Approve Suite is not affiliated with Trevi Therapeutics.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.